The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of comprehensive circulating tumor DNA (ctDNA) testing compared to standard-of-care (SoC) tissue testing in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts).
 
Manuel Benavides
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Sysmex; Sysmex; Sysmex; Sysmex
Travel, Accommodations, Expenses - Merck; Merck; Merck; Merck; Roche; Roche; Roche; Roche
 
Julia Alcaide
No Relationships to Disclose
 
Martina Alvarez
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene
 
Esperanza Torres
Honoraria - Bayer; Bayer; Bayer; Bayer
 
Isabel Sevilla
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Novartis Pharmaceuticals UK Ltd.; Novartis Pharmaceuticals UK Ltd.; Novartis Pharmaceuticals UK Ltd.; Novartis Pharmaceuticals UK Ltd.; Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen
 
Silvia Gil Calle
No Relationships to Disclose
 
Carmen Reyna
Employment - VISUfarma (I); VISUfarma (I); VISUfarma (I); VISUfarma (I)
Stock and Other Ownership Interests - VISUfarma (I); VISUfarma (I); VISUfarma (I); VISUfarma (I)
Consulting or Advisory Role - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche; Roche; Roche; Roche
 
Inmaculada Alés
No Relationships to Disclose
 
Gema Durán
No Relationships to Disclose
 
Roberto Wolman
Honoraria - Kirin Pharmaceuticals; Kirin Pharmaceuticals; Kirin Pharmaceuticals; Kirin Pharmaceuticals
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche
 
Mireya Cazorla
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen
 
Pedro Jimenez Gallego
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Irene López
No Relationships to Disclose
 
Alexandra Cantero
No Relationships to Disclose
 
Ana Godoy
No Relationships to Disclose
 
Richard B. Lanman
Employment - Guardant Health; Guardant Health; Guardant Health; Guardant Health; Veracyte; Veracyte; Veracyte; Veracyte
Leadership - Biolase; Biolase; Biolase; Biolase; Guardant Health; Guardant Health; Guardant Health; Guardant Health
Stock and Other Ownership Interests - Biolase; Biolase; Biolase; Biolase; Forward; Forward; Forward; Forward; Guardant Health; Guardant Health; Guardant Health; Guardant Health
Consulting or Advisory Role - Forward; Forward; Forward; Forward
Research Funding - Guardant Health; Guardant Health; Guardant Health; Guardant Health
 
Iris Faull
Employment - Guardant Health; Guardant Health; Guardant Health; Guardant Health; Nanostring Technologies; Nanostring Technologies; Nanostring Technologies; Nanostring Technologies
Stock and Other Ownership Interests - Guardant Health; Guardant Health; Guardant Health; Guardant Health; Nanostring Technologies; Nanostring Technologies; Nanostring Technologies; Nanostring Technologies
Honoraria - Guardant Health; Guardant Health; Guardant Health; Guardant Health; NanoString Technologies; NanoString Technologies; NanoString Technologies; NanoString Technologies
Travel, Accommodations, Expenses - Guardant Health; Guardant Health; Guardant Health; Guardant Health; NanoString Technologies; NanoString Technologies; NanoString Technologies; NanoString Technologies
 
Justin Odegaard
Employment - Guardant Health; Guardant Health; Guardant Health; Guardant Health
Stock and Other Ownership Interests - Guardant Health; Guardant Health; Guardant Health; Guardant Health
 
Il Jin Kim
Employment - Guardant Health; Guardant Health; Guardant Health; Guardant Health
Leadership - CureSeq; CureSeq; CureSeq; CureSeq
Stock and Other Ownership Interests - Guardant Health; Guardant Health; Guardant Health; Guardant Health
Consulting or Advisory Role - CureSeq; CureSeq; CureSeq; CureSeq; TRACON Pharma; TRACON Pharma; TRACON Pharma; TRACON Pharma
Patents, Royalties, Other Intellectual Property - University of California, San Francisco; University of California, San Francisco; University of California, San Francisco; University of California, San Francisco
 
Emilio Alba
Consulting or Advisory Role - Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme